Biosimilar Market is Expected To Grow at a CAGR of 25.1% by 2032

added article Health

2024-11-06 06:00:30 -

Global Biosimilar Market Size, Share, Trends & Growth Report 2024-2032 The global biosimilar market size reached USD 21.2 billion in 2023. The market is expected to reach USD 164.5 Billion by 2032, exhibiting a growth rate (CAGR) of 25.1% during 2024-2032. Europe leads the market, accounting for the largest biosimilar market share. Infliximab accounts for the majority of the market share...

0 Comments 0 Shares 57 Views 0 Reviews